Antineoplastic AgentsDose-Response Relationship, DrugDrug Evaluation, PreclinicalTreatment OutcomeNanoparticlesCell Line, TumorDrug Administration ScheduleAntineoplastic Combined Chemotherapy ProtocolsCancer VaccinesToxicity TestsCombined Modality TherapyGenetic TherapyDrug SynergismNeoplasmsLiposomesCell SurvivalMice, NudeXenograft Model Antitumor AssaysSurvival AnalysisAntibodies, MonoclonalTime FactorsToxicity Tests, AcuteLethal Dose 50Toxicity Tests, ChronicCisplatinInfusions, IntravenousNo-Observed-Adverse-Effect LevelFluorouracilMaximum Tolerated DoseAdministration, OralDoxorubicinToxicologyDeoxycytidineDrug EvaluationLeukopeniaAntineoplastic Agents, PhytogenicDrug-Related Side Effects and Adverse ReactionsAntimetabolites, AntineoplasticRadiation InjuriesPaclitaxelDrug-Induced Liver InjuryLiverNeutropeniaToxicity Tests, SubchronicAntidotesCamptothecinCyclophosphamideDisease-Free SurvivalRadiotherapy DosageCarboplatinHematologic DiseasesLung NeoplasmsTaxoidsTeratogensSurvival RateOrganoplatinum CompoundsWater Pollutants, ChemicalLeucovorinThrombocytopeniaEtoposideAnimal Testing AlternativesEnvironmental PollutantsGlutathioneRats, Sprague-DawleyInsecticidesVinblastineMethotrexateRadiotherapyAntineoplastic Agents, AlkylatingDrug InteractionsOrgan SizeCells, CulturedNauseaToxicity Tests, SubacuteNeurotoxicity SyndromesPlant ExtractsDose FractionationVincristineBody WeightAntibiotics, AntineoplasticRadiotherapy, ConformalArea Under CurveOxidative StressNeoplasm StagingKidneyNeoplasm MetastasisAcetaminophenPlant PoisoningApoptosisTissue DistributionRemission InductionCell LineNeoplasm Recurrence, LocalCell DeathInjections, IntravenousSalvage TherapyStomatitisRadioimmunotherapyProdrugsRats, Inbred F344